DEA Notice: Sterling Wisconsin LLC Controlled Substances Application

FR: Drug Enforcement Administration

Published March 19th, 2026

Detected March 19th, 2026

Summary

The Drug Enforcement Administration (DEA) has published a notice regarding an application from Sterling Wisconsin, LLC to be registered as a bulk manufacturer of various controlled substances, including Schedule I and II drugs. The public has until May 18, 2026, to submit comments or objections.

View original document View source feed page

What changed

The Drug Enforcement Administration (DEA) has issued a notice concerning an application from Sterling Wisconsin, LLC, located in Germantown, Wisconsin, to be registered as a bulk manufacturer of controlled substances. The application includes a range of substances, notably Lysergic Acid Diethylamide, Marihuana Extract, Marihuana, Tetrahydrocannabinols, Mescaline, Psilocybin, Oliceridine, Thebaine, and Alfentanil, with several classified under Schedule I and II. The company intends to manufacture these substances synthetically for commercial sale.

Regulated entities, specifically other registered bulk manufacturers and applicants, have until May 18, 2026, to submit electronic comments or objections to this application. A written request for a hearing on the matter can also be filed by the same date. Failure to act by this deadline may result in the approval of Sterling Wisconsin, LLC's registration without further opportunity for public input or objection.

What to do next

Submit electronic comments or objections to the DEA application by May 18, 2026.
File a written request for a hearing by May 18, 2026, if desired.

Source document (simplified)

Notice

Bulk Manufacturer of Controlled Substances Application: Sterling Wisconsin, LLC

A Notice by the Drug Enforcement Administration on 03/19/2026

This document has a comment period that ends in 60 days.
(05/18/2026) View Comment Instructions
PDF
Document Details
Document Dates

- Table of Contents

Public Comments
Regulations.gov Data

- Sharing

Print
Other Formats
Public Inspection Published Document: 2026-05357 (91 FR 13338) Document Headings ###### Department of Justice

Drug Enforcement Administration

[Docket No. DEA-1675]

AGENCY:

Drug Enforcement Administration, Justice.

ACTION:

Notice of application.

SUMMARY:

Sterling Wisconsin, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

DATES:

Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before May 18, 2026. Such persons may also file a written request for a hearing on the application on or before May 18, 2026.

ADDRESSES:

The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment.

SUPPLEMENTARY INFORMATION:

In accordance with 21 CFR 1301.33(a), this is notice that on January 27, 2026, Sterling Wisconsin, LLC, W130N10497 Washington Drive, Germantown, Wisconsin 53022-4448, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substance(s): ( printed page 13339)

| Controlled substance | Drug
code | Schedule |
| --- | --- | --- |
| Lysergic Acid Diethylamide | 7315 | I |
| Marihuana Extract | 7350 | I |
| Marihuana | 7360 | I |
| Tetrahydrocannabinols | 7370 | I |
| Mescaline | 7381 | I |
| 5-Methoxy-N-N-Dimethyltryptamine | 7431 | I |
| Psilocybin | 7437 | I |
| Oliceridine | 9245 | II |
| Thebaine | 9333 | II |
| Alfentanil | 9737 | II |
The company plans to bulk manufacture the listed controlled substances for commercial sale to its customers. In reference to drug codes 7350 (Marihuana Extract), 7360 (Marihuana), and 7370 (Tetrahydrocannabinols), the company plans to bulk manufacture these drugs as synthetic. No other activities for these drug codes are authorized for this registration.

Thomas Prevoznik,

Deputy Assistant Administrator.

[FR Doc. 2026-05357 Filed 3-18-26; 8:45 am]

BILLING CODE P

Published Document: 2026-05357 (91 FR 13338)